PI
XENE icon

PEAK6 Investments’s Xenon Pharmaceuticals XENE Stock Holding History

PEAK6 Investments’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$315K Hold
8,000
– – ﹤0.01% 2567
2024
Q2 		$312K Buy
+8,000
New +$320K ﹤0.01% 2519

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

PEAK6 Investments's XENE Position: Q3 2024 in Review

PEAK6 Investments held its Xenon Pharmaceuticals (XENE) position steady in Q3 2024 at 8,000 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #2567.

PEAK6 Investments first reported a position in XENE in Q2 2024 and has held it in 2 quarters since. 203 funds tracked by Wall St. Rank hold XENE as of Q3 2024.

  • PEAK6 Investments held 8,000 shares of Xenon Pharmaceuticals worth $315K as of Q3 2024.
  • PEAK6 Investments left its Xenon Pharmaceuticals share count unchanged in Q3 2024.
  • Xenon Pharmaceuticals made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2567 holding.
  • PEAK6 Investments first reported a position in Xenon Pharmaceuticals in Q2 2024 and has held it in 2 quarters since.
  • 203 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.